Kbc Group Nv Endo International PLC Transaction History

Kbc Group Nv

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Feb 14, 2024	BUY	$0.3 - $2.74 $6,358 - $58,074	21,195 New	21,195 $10,000
Q2 2022 Jul 26, 2022	BUY	$0.3 - $2.74 $6,358 - $58,074	21,195 New	21,195 $10,000
Q4 2020 Feb 10, 2021	SELL	$3.33 - $7.18 $57,345 - $123,646	-17,221 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$2.28 - $6.6 $177,876 - $514,905	-78,016 Reduced 81.92%	17,221 $64,000
Q4 2019 Feb 11, 2020	SELL	$3.34 - $5.51 $33,987 - $56,069	-10,176 Reduced 9.65%	95,237 $447,000
Q1 2019 May 10, 2019	SELL	$7.71 - $11.24 $1.67 Million - $2.44 Million	-217,149 Reduced 67.32%	105,413 $0
Q4 2018 Jan 31, 2019	SELL	$7.3 - $18.3 $988,376 - $2.48 Million	-135,394 Reduced 29.56%	322,562 $2.35 Million
Q3 2018 Nov 14, 2018	BUY	$9.77 - $17.15 $4.3 Million - $7.55 Million	440,499 Added 2523.34%	457,956 $0
Q2 2018 Aug 03, 2018	SELL	$5.43 - $9.83 $1.26 Million - $2.28 Million	-232,074 Reduced 93.0%	17,457 $0
Q1 2018 May 09, 2018	BUY	$5.79 - $8.86 $987,316 - $1.51 Million	170,521 Added 215.82%	249,531 $0
Q4 2017 Feb 07, 2018	SELL	$5.88 - $9.09 $3.31 Million - $5.12 Million	-563,276 Reduced 87.7%	79,010 $0
Q3 2017 Nov 13, 2017	BUY	$7.55 - $9.43 $4.85 Million - $6.06 Million	642,286	642,286 $0

Ticker ENDP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 235,143,008
Market Cap $68.8M
Description
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocio...

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

Stay updated on Kbc Group Nv with notifications on news.